Lansdale, PA, United States of America

Roberta L McKee

This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 1992.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Roberta L McKee: Innovator in Peptide Analogues

Introduction

Roberta L McKee is a distinguished inventor based in Lansdale, PA (US). She has made significant contributions to the field of biochemistry, particularly in the development of peptide analogues. Her work focuses on the inhibition of naturally occurring peptides, which has important implications for medical research and treatment.

Latest Patents

Roberta holds a patent for "Humoral hypercalcemic factor antagonists." This invention relates to the use of peptide analogues as inhibitors of their respective naturally occurring peptides. The structure of these peptide analogues is exemplified by an internal region of the N-terminus of humoral hypercalcemic factor hHCF, along with various truncations and amino acid substitutions. She has been granted 1 patent for her innovative work.

Career Highlights

Roberta is currently employed at Merck & Co., Inc., where she continues to advance her research in peptide analogues. Her career has been marked by a commitment to scientific excellence and innovation.

Collaborations

Throughout her career, Roberta has collaborated with notable colleagues, including Michael Rosenblatt and Michael P Caulfield. These partnerships have enriched her research and contributed to her success in the field.

Conclusion

Roberta L McKee is a prominent figure in the realm of peptide research, with a focus on developing inhibitors for naturally occurring peptides. Her contributions to science and her innovative spirit continue to inspire future advancements in biochemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…